TA
JAZZ icon

Tectonic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tectonic Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
5,896
-56
-0.9% -$12.3K 0.07% 152
2026
Q1 		$1.13M Buy
5,952
+292
+5% +$51K 0.06% 155
2025
Q4 		$962K Buy
5,660
+34
+0.6% +$5.21K 0.05% 173
2025
Q3 		$742K Buy
5,626
+82
+1% +$9.84K 0.04% 196
2025
Q2 		$588K Buy
5,544
+927
+20% +$101K 0.03% 232
2025
Q1 		$573K Buy
4,617
+243
+6% +$31.7K 0.04% 222
2024
Q4 		$539K Buy
4,374
+483
+12% +$56.9K 0.04% 226
2024
Q3 		$433K Buy
3,891
+232
+6% +$25.4K 0.03% 258
2024
Q2 		$391K Buy
3,659
+429
+13% +$47.2K 0.03% 261
2024
Q1 		$389K Buy
3,230
+540
+20% +$66.1K 0.03% 246
2023
Q4 		$331K Buy
2,690
+283
+12% +$35.3K 0.03% 248
2023
Q3 		$312K Buy
+2,407
New +$321K 0.03% 232

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Tectonic Advisors's JAZZ Position: Q2 2026 in Review

Tectonic Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.94% in Q2 2026, selling an estimated $12.3K and leaving 5,896 shares worth $1.42M. The position accounts for 0.07% of the portfolio, ranked #152.

Tectonic Advisors first reported a position in JAZZ in Q3 2023 and has held it in 12 quarters since. 90 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Tectonic Advisors held 5,896 shares of Jazz Pharmaceuticals worth $1.42M as of Q2 2026.
  • Tectonic Advisors sold 56 Jazz Pharmaceuticals shares in Q2 2026, an estimated $12.3K.
  • Jazz Pharmaceuticals made up 0.07% of Tectonic Advisors's portfolio in Q2 2026, its #152 holding.
  • Tectonic Advisors first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 90 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.